| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-24 ERVK-8 | 3.00e-12 | 37 | 206 | 10 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-24 ERVK-8 | 4.03e-12 | 38 | 206 | 10 | GO:0070001 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.89e-08 | 11 | 206 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.07e-07 | 14 | 206 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 3.07e-07 | 15 | 206 | 5 | GO:0005005 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.15e-06 | 19 | 206 | 5 | GO:0005003 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.98e-06 | 21 | 206 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.74e-05 | 79 | 206 | 7 | GO:0004521 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 ATAD5 CHD3 ERVK-7 ERVK-10 ERVK-11 SMARCA5 ERVK-8 SMARCA1 SMARCA2 SMARCA4 TOP2B | 1.88e-05 | 262 | 206 | 12 | GO:0140097 |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 2.12e-05 | 6 | 206 | 3 | GO:0034647 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.71e-05 | 37 | 206 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.71e-05 | 37 | 206 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 ATAD5 CHD3 ERVK-7 ERVK-10 IFIH1 ENDOU ERVK-11 SMARCA5 VARS2 TARS3 TRMT2A TRMT44 ERVK-8 SMARCA1 SMARCA2 SMARCA4 CPSF3 TOP2B | 4.19e-05 | 645 | 206 | 19 | GO:0140640 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 4.24e-05 | 38 | 206 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 5.58e-05 | 65 | 206 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 5.83e-05 | 8 | 206 | 3 | GO:0032453 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATAD5 ABCA12 NAIP ACTC1 NUBP1 CHD3 DNAH14 IFIH1 ABCC1 SMARCA5 DNAH7 CCT6A DNAI2 SMARCA1 SMARCA2 SMARCA4 CCT6B TOP2B | 7.13e-05 | 614 | 206 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 KDM5B KDM5C PTGR2 CHD3 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZKSCAN5 F8 FBXL5 IFIH1 HPD DTX4 ERVK-19 ENDOU DNAJC24 UROD ERVK-24 ERVK-11 FN1 KDM5A RBM20 LTN1 ERVK-8 ERVK-5 | 9.74e-05 | 1189 | 206 | 27 | GO:0046914 |
| GeneOntologyMolecularFunction | interleukin-18 receptor activity | 1.06e-04 | 2 | 206 | 2 | GO:0042008 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.08e-04 | 46 | 206 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | endopeptidase activity | PRSS54 ERVK-6 ADAM19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-24 ERVK-8 MST1L PCSK4 | 1.59e-04 | 430 | 206 | 14 | GO:0004175 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.49e-04 | 85 | 206 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 2.87e-04 | 13 | 206 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 3.16e-04 | 3 | 206 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.53e-04 | 127 | 206 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 CLDN18 SEH1L ACTA1 OBSCN ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-24 FN1 CLDN7 SEC31A CRYBA1 CRYBA4 ERVK-8 ERVK-5 POTEJ | 3.73e-04 | 891 | 206 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 KDM5B KDM5C PTGR2 CHD3 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZKSCAN5 IFIH1 DTX4 ERVK-19 DNAJC24 ERVK-24 ERVK-11 KDM5A RBM20 LTN1 ERVK-8 ERVK-5 | 3.73e-04 | 891 | 206 | 21 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 5.33e-04 | 136 | 206 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 5.33e-04 | 136 | 206 | 7 | GO:0004519 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.43e-04 | 229 | 206 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | tRNA (uridine) methyltransferase activity | 1.04e-03 | 5 | 206 | 2 | GO:0016300 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.04e-03 | 5 | 206 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | peptidase activity | PRSS54 ERVK-6 ADAM19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-18 ERVK-19 ENDOU ERVK-25 ERVK-24 USP53 ERVK-8 MST1L PCSK4 | 1.28e-03 | 654 | 206 | 16 | GO:0008233 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 ERVK-7 ERVK-10 IFIH1 ENDOU ERVK-11 VARS2 TARS3 TRMT2A TRMT44 ERVK-8 CPSF3 | 1.36e-03 | 417 | 206 | 12 | GO:0140098 |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.55e-03 | 6 | 206 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 2.15e-03 | 7 | 206 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATAD5 ABCA12 NAIP NUBP1 CHD3 IFIH1 ABCC1 SMARCA5 DNAH7 CCT6A SMARCA4 CCT6B | 2.17e-03 | 441 | 206 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | interleukin-1 receptor activity | 2.85e-03 | 8 | 206 | 2 | GO:0004908 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 2.93e-03 | 28 | 206 | 3 | GO:0141052 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.06e-07 | 13 | 203 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 9.26e-06 | 5 | 203 | 3 | GO:0090131 | |
| GeneOntologyCellularComponent | interleukin-18 receptor complex | 9.48e-05 | 2 | 204 | 2 | GO:0045092 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.13e-07 | 14 | 194 | 5 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.13e-07 | 14 | 194 | 5 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.13e-07 | 14 | 194 | 5 | IPR001426 | |
| Domain | EphA2_TM | 2.13e-07 | 14 | 194 | 5 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.13e-07 | 14 | 194 | 5 | IPR001090 | |
| Domain | Eph_TM | 2.13e-07 | 14 | 194 | 5 | IPR027936 | |
| Domain | EPH_lbd | 2.13e-07 | 14 | 194 | 5 | SM00615 | |
| Domain | Ephrin_lbd | 2.13e-07 | 14 | 194 | 5 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.13e-07 | 14 | 194 | 5 | IPR016257 | |
| Domain | EPH_LBD | 2.13e-07 | 14 | 194 | 5 | PS51550 | |
| Domain | - | 8.85e-07 | 73 | 194 | 8 | 2.60.120.260 | |
| Domain | fn3 | EPHB2 EPHB3 EPHB6 EPHA6 OBSCN LRFN4 PTPRZ1 CNTN5 FN1 TNR EPHB1 | 1.04e-06 | 162 | 194 | 11 | PF00041 |
| Domain | FN3 | EPHB2 EPHB3 EPHB6 EPHA6 OBSCN LRFN4 PTPRZ1 CNTN5 FN1 TNR EPHB1 | 3.82e-06 | 185 | 194 | 11 | SM00060 |
| Domain | Lys_sp_deMease-like_dom | 4.38e-06 | 4 | 194 | 3 | IPR013637 | |
| Domain | PLU-1 | 4.38e-06 | 4 | 194 | 3 | PF08429 | |
| Domain | Ephrin_rec_like | 5.15e-06 | 25 | 194 | 5 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.15e-06 | 25 | 194 | 5 | IPR011641 | |
| Domain | Galactose-bd-like | 6.09e-06 | 94 | 194 | 8 | IPR008979 | |
| Domain | FN3 | EPHB2 EPHB3 EPHB6 EPHA6 OBSCN LRFN4 PTPRZ1 CNTN5 FN1 TNR EPHB1 | 7.68e-06 | 199 | 194 | 11 | PS50853 |
| Domain | zf-C5HC2 | 1.09e-05 | 5 | 194 | 3 | PF02928 | |
| Domain | Znf_C5HC2 | 1.09e-05 | 5 | 194 | 3 | IPR004198 | |
| Domain | FN3_dom | EPHB2 EPHB3 EPHB6 EPHA6 OBSCN LRFN4 PTPRZ1 CNTN5 FN1 TNR EPHB1 | 1.22e-05 | 209 | 194 | 11 | IPR003961 |
| Domain | SNF2_N | 1.84e-05 | 32 | 194 | 5 | IPR000330 | |
| Domain | SNF2_N | 1.84e-05 | 32 | 194 | 5 | PF00176 | |
| Domain | Actin_CS | 1.86e-05 | 16 | 194 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 2.42e-05 | 17 | 194 | 4 | PS00432 | |
| Domain | Actin/actin-like_CS | 3.08e-05 | 18 | 194 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 3.87e-05 | 19 | 194 | 4 | PS01132 | |
| Domain | ACTINS_1 | 5.95e-05 | 8 | 194 | 3 | PS00406 | |
| Domain | BTB-kelch_protein | 8.02e-05 | 43 | 194 | 5 | IPR017096 | |
| Domain | Ataxin-2_C | 8.85e-05 | 9 | 194 | 3 | IPR009818 | |
| Domain | PAM2 | 8.85e-05 | 9 | 194 | 3 | PF07145 | |
| Domain | SM_dom_ATX | 1.07e-04 | 2 | 194 | 2 | IPR025852 | |
| Domain | Gln-Leu-Gln_QLQ | 1.07e-04 | 2 | 194 | 2 | IPR014978 | |
| Domain | Chap_CCT_zeta | 1.07e-04 | 2 | 194 | 2 | IPR012722 | |
| Domain | SnAC | 1.07e-04 | 2 | 194 | 2 | PF14619 | |
| Domain | QLQ | 1.07e-04 | 2 | 194 | 2 | SM00951 | |
| Domain | SLIDE | 1.07e-04 | 2 | 194 | 2 | IPR015195 | |
| Domain | ISWI_HAND-dom | 1.07e-04 | 2 | 194 | 2 | IPR015194 | |
| Domain | LsmAD | 1.07e-04 | 2 | 194 | 2 | PF06741 | |
| Domain | LsmAD_domain | 1.07e-04 | 2 | 194 | 2 | IPR009604 | |
| Domain | Hist_acetylase_PCAF | 1.07e-04 | 2 | 194 | 2 | IPR016376 | |
| Domain | QLQ | 1.07e-04 | 2 | 194 | 2 | PS51666 | |
| Domain | FAM78 | 1.07e-04 | 2 | 194 | 2 | IPR029638 | |
| Domain | LsmAD | 1.07e-04 | 2 | 194 | 2 | SM01272 | |
| Domain | SnAC | 1.07e-04 | 2 | 194 | 2 | SM01314 | |
| Domain | PCAF_N | 1.07e-04 | 2 | 194 | 2 | IPR009464 | |
| Domain | SnAC | 1.07e-04 | 2 | 194 | 2 | IPR029295 | |
| Domain | SLIDE | 1.07e-04 | 2 | 194 | 2 | PF09111 | |
| Domain | HAND | 1.07e-04 | 2 | 194 | 2 | PF09110 | |
| Domain | SM-ATX | 1.07e-04 | 2 | 194 | 2 | PF14438 | |
| Domain | QLQ | 1.07e-04 | 2 | 194 | 2 | PF08880 | |
| Domain | PCAF_N | 1.07e-04 | 2 | 194 | 2 | PF06466 | |
| Domain | ISWI | 1.07e-04 | 2 | 194 | 2 | IPR029915 | |
| Domain | TF_fork_head_CS_2 | 1.11e-04 | 46 | 194 | 5 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 1.24e-04 | 47 | 194 | 5 | IPR018122 | |
| Domain | JmjN | 1.25e-04 | 10 | 194 | 3 | SM00545 | |
| Domain | JmjN | 1.25e-04 | 10 | 194 | 3 | PF02375 | |
| Domain | JMJN | 1.25e-04 | 10 | 194 | 3 | PS51183 | |
| Domain | JmjN | 1.25e-04 | 10 | 194 | 3 | IPR003349 | |
| Domain | Bromodomain_CS | 1.41e-04 | 26 | 194 | 4 | IPR018359 | |
| Domain | FH | 1.51e-04 | 49 | 194 | 5 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.51e-04 | 49 | 194 | 5 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.51e-04 | 49 | 194 | 5 | PS00658 | |
| Domain | Fork_head_dom | 1.51e-04 | 49 | 194 | 5 | IPR001766 | |
| Domain | FORK_HEAD_3 | 1.51e-04 | 49 | 194 | 5 | PS50039 | |
| Domain | Forkhead | 1.51e-04 | 49 | 194 | 5 | PF00250 | |
| Domain | - | 1.64e-04 | 27 | 194 | 4 | 2.130.10.80 | |
| Domain | Ephrin_rec_like | 1.71e-04 | 11 | 194 | 3 | PF07699 | |
| Domain | - | EPHB2 EPHB3 EPHB6 FCRL2 EPHA6 PDGFRA OBSCN IL18RAP IL18R1 LRFN4 PTPRZ1 CNTN5 UNC5D FN1 LY9 TNR FCMR EPHB1 | 1.98e-04 | 663 | 194 | 18 | 2.60.40.10 |
| Domain | Actin | 2.85e-04 | 31 | 194 | 4 | IPR004000 | |
| Domain | Actin | 2.85e-04 | 31 | 194 | 4 | PF00022 | |
| Domain | ACTIN | 2.85e-04 | 31 | 194 | 4 | SM00268 | |
| Domain | GPCR_2_brain_angio_inhib | 3.20e-04 | 3 | 194 | 2 | IPR008077 | |
| Domain | DBINO | 3.20e-04 | 3 | 194 | 2 | IPR020838 | |
| Domain | DBINO | 3.20e-04 | 3 | 194 | 2 | PF13892 | |
| Domain | Kelch | 3.37e-04 | 58 | 194 | 5 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 3.65e-04 | 59 | 194 | 5 | IPR011043 | |
| Domain | BACK | 3.95e-04 | 60 | 194 | 5 | SM00875 | |
| Domain | Gal_Oxidase_b-propeller | 4.10e-04 | 34 | 194 | 4 | IPR015916 | |
| Domain | Ig-like_fold | EPHB2 EPHB3 EPHB6 FCRL2 EPHA6 PDGFRA OBSCN IL18RAP IL18R1 LRFN4 PTPRZ1 CNTN5 UNC5D FN1 LY9 TNR FCMR EPHB1 | 4.21e-04 | 706 | 194 | 18 | IPR013783 |
| Domain | BACK | 4.26e-04 | 61 | 194 | 5 | IPR011705 | |
| Domain | BACK | 4.26e-04 | 61 | 194 | 5 | PF07707 | |
| Domain | - | 4.58e-04 | 15 | 194 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 4.58e-04 | 15 | 194 | 3 | SM00501 | |
| Domain | ARID_dom | 4.58e-04 | 15 | 194 | 3 | IPR001606 | |
| Domain | ARID | 4.58e-04 | 15 | 194 | 3 | PS51011 | |
| Domain | ARID | 4.58e-04 | 15 | 194 | 3 | PF01388 | |
| Domain | TSP_1 | 4.95e-04 | 63 | 194 | 5 | PF00090 | |
| Domain | PROTEIN_KINASE_TYR | 5.25e-04 | 97 | 194 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.25e-04 | 97 | 194 | 6 | IPR008266 | |
| Domain | BROMODOMAIN_1 | 5.70e-04 | 37 | 194 | 4 | PS00633 | |
| Domain | TSP1 | 5.72e-04 | 65 | 194 | 5 | SM00209 | |
| Domain | TSP1_rpt | 5.72e-04 | 65 | 194 | 5 | IPR000884 | |
| Domain | TSP1 | 5.72e-04 | 65 | 194 | 5 | PS50092 | |
| Domain | Bromodomain | 6.32e-04 | 38 | 194 | 4 | PF00439 | |
| Domain | HSA | 6.35e-04 | 4 | 194 | 2 | SM00573 | |
| Domain | Carboxyl_trans | 6.35e-04 | 4 | 194 | 2 | PF01039 | |
| Domain | HSA | 6.35e-04 | 4 | 194 | 2 | PS51204 | |
| Domain | COA_CT_CTER | 6.35e-04 | 4 | 194 | 2 | PS50989 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.35e-05 | 34 | 145 | 5 | MM15025 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.94e-05 | 18 | 145 | 4 | MM15024 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 3.69e-05 | 19 | 145 | 4 | M27310 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | KDM5B KDM5C CHD3 KAT2A EZH2 KAT2B KDM5A PRMT6 SMARCA2 SMARCA4 KAT14 | 1.16e-04 | 272 | 145 | 11 | M29619 |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.72e-04 | 51 | 145 | 5 | M27311 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-24 ERVK-11 ERVK-8 ERVK-5 | 5.00e-13 | 94 | 209 | 12 | 21542922 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 7.47e-12 | 5 | 209 | 5 | 12629516 | |
| Pubmed | 7.70e-12 | 18 | 209 | 7 | 18664271 | ||
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 7.66e-10 | 18 | 209 | 6 | 18651661 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.27e-09 | 4 | 209 | 4 | 10469592 | |
| Pubmed | 1.27e-09 | 4 | 209 | 4 | 7983737 | ||
| Pubmed | 1.58e-09 | 20 | 209 | 6 | 12812790 | ||
| Pubmed | 5.72e-09 | 12 | 209 | 5 | 14557543 | ||
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 1.88e-08 | 6 | 209 | 4 | 27092474 | |
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 2.14e-08 | 15 | 209 | 5 | 7689224 | |
| Pubmed | 2.14e-08 | 15 | 209 | 5 | 22045912 | ||
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 4.36e-08 | 17 | 209 | 5 | 12217323 | |
| Pubmed | 6.01e-08 | 18 | 209 | 5 | 36280666 | ||
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 8.11e-08 | 19 | 209 | 5 | 12684176 | |
| Pubmed | The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization. | 8.70e-08 | 8 | 209 | 4 | 8530406 | |
| Pubmed | 1.41e-07 | 21 | 209 | 5 | 9267020 | ||
| Pubmed | 1.41e-07 | 21 | 209 | 5 | 11128993 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 1.41e-07 | 21 | 209 | 5 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 1.41e-07 | 21 | 209 | 5 | 20112066 | |
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 1.41e-07 | 21 | 209 | 5 | 10730216 | |
| Pubmed | An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution. | 1.56e-07 | 9 | 209 | 4 | 12412011 | |
| Pubmed | 1.56e-07 | 9 | 209 | 4 | 11580899 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 9971820 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 38230606 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 25051176 | ||
| Pubmed | Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. | 2.14e-07 | 3 | 209 | 3 | 14691139 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 28292935 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 11359880 | ||
| Pubmed | A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development. | 2.14e-07 | 3 | 209 | 3 | 23143520 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 10516026 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 26645689 | ||
| Pubmed | EphB receptors couple dendritic filopodia motility to synapse formation. | 2.14e-07 | 3 | 209 | 3 | 18614029 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 2.14e-07 | 3 | 209 | 3 | 7780165 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 29731254 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 35025117 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 22622783 | ||
| Pubmed | Retinal axon growth cones respond to EphB extracellular domains as inhibitory axon guidance cues. | 2.14e-07 | 3 | 209 | 3 | 11532925 | |
| Pubmed | 2.22e-07 | 43 | 209 | 6 | 26030138 | ||
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 2.30e-07 | 23 | 209 | 5 | 19542359 | |
| Pubmed | EphB signaling regulates target innervation in the developing and deafferented auditory brainstem. | 2.59e-07 | 10 | 209 | 4 | 22021100 | |
| Pubmed | EphB2 guides axons at the midline and is necessary for normal vestibular function. | 2.59e-07 | 10 | 209 | 4 | 10839360 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 2.89e-07 | 24 | 209 | 5 | 16446123 | |
| Pubmed | 5.05e-07 | 157 | 209 | 9 | 30186101 | ||
| Pubmed | Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. | 8.52e-07 | 4 | 209 | 3 | 16541399 | |
| Pubmed | EphB2 receptor forward signaling controls cortical growth cone collapse via Nck and Pak. | 8.52e-07 | 4 | 209 | 3 | 23147113 | |
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 22475621 | ||
| Pubmed | Eph receptor deficiencies lead to altered cochlear function. | 8.52e-07 | 4 | 209 | 3 | 12684184 | |
| Pubmed | GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking. | 8.52e-07 | 4 | 209 | 3 | 15965473 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SART3 ACTA1 ACTA2 ACTC1 CHD3 ESYT2 SMARCA5 SMARCA1 SMARCA4 POTEJ TOP2B | 8.59e-07 | 271 | 209 | 11 | 32433965 |
| Pubmed | Pygo1 regulates pathological cardiac hypertrophy via a β-catenin-dependent mechanism. | 8.68e-07 | 13 | 209 | 4 | 33635162 | |
| Pubmed | A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype. | 8.68e-07 | 13 | 209 | 4 | 16884697 | |
| Pubmed | 8.68e-07 | 13 | 209 | 4 | 7957066 | ||
| Pubmed | ATAD5 ABCA12 KDM5C SRP9 CHD3 KAT2A ZKSCAN5 KAT2B MTUS1 MTO1 UNC5D SMARCA5 HECTD3 KDM5A TRMT2A CADPS LTN1 SMARCA1 SMARCA2 ZBTB10 SMARCA4 KAT14 | 1.19e-06 | 1116 | 209 | 22 | 31753913 | |
| Pubmed | 1.32e-06 | 32 | 209 | 5 | 23369715 | ||
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 1.55e-06 | 33 | 209 | 5 | 26864203 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 2.12e-06 | 5 | 209 | 3 | 11401426 | |
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 12234674 | ||
| Pubmed | Critical roles for EphB and ephrin-B bidirectional signalling in retinocollicular mapping. | 2.12e-06 | 5 | 209 | 3 | 21847105 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 2.12e-06 | 5 | 209 | 3 | 21559471 | |
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 2.18e-06 | 16 | 209 | 4 | 8861101 | |
| Pubmed | 2.18e-06 | 16 | 209 | 4 | 10208738 | ||
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 2.84e-06 | 17 | 209 | 4 | 12971893 | |
| Pubmed | 2.84e-06 | 17 | 209 | 4 | 8997639 | ||
| Pubmed | Genome-scale study of transcription factor expression in the branching mouse lung. | 3.22e-06 | 67 | 209 | 6 | 22711520 | |
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 3.63e-06 | 18 | 209 | 4 | 28068325 | |
| Pubmed | 4.14e-06 | 40 | 209 | 5 | 30898150 | ||
| Pubmed | Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. | 4.22e-06 | 6 | 209 | 3 | 21960634 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 4.22e-06 | 6 | 209 | 3 | 9971772 | |
| Pubmed | Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. | 4.22e-06 | 6 | 209 | 3 | 15347669 | |
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 26148571 | ||
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 4.22e-06 | 6 | 209 | 3 | 10074138 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 4.22e-06 | 6 | 209 | 3 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 4.22e-06 | 6 | 209 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 4.22e-06 | 6 | 209 | 3 | 11709093 | |
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 10049817 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 12009869 | ||
| Pubmed | Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord. | 4.22e-06 | 6 | 209 | 3 | 16786562 | |
| Pubmed | Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning. | 4.22e-06 | 6 | 209 | 3 | 19182796 | |
| Pubmed | Abnormal hippocampal axon bundling in EphB receptor mutant mice. | 4.22e-06 | 6 | 209 | 3 | 15014111 | |
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 15063128 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 4.22e-06 | 6 | 209 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 4.22e-06 | 6 | 209 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 4.22e-06 | 6 | 209 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 4.22e-06 | 6 | 209 | 3 | 8661406 | |
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 23017337 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 4.22e-06 | 6 | 209 | 3 | 23875777 | |
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 9841925 | ||
| Pubmed | Functional equivalency between Otx2 and Otx1 in development of the rostral head. | 4.58e-06 | 19 | 209 | 4 | 9895322 | |
| Pubmed | 4.69e-06 | 41 | 209 | 5 | 23676014 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 5.30e-06 | 42 | 209 | 5 | 11439183 | |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 5.69e-06 | 20 | 209 | 4 | 11256076 | |
| Pubmed | 5.69e-06 | 20 | 209 | 4 | 10207129 | ||
| Pubmed | 5.69e-06 | 20 | 209 | 4 | 9530499 | ||
| Pubmed | 5.69e-06 | 20 | 209 | 4 | 9576626 | ||
| Pubmed | 6.25e-06 | 75 | 209 | 6 | 25593309 | ||
| Pubmed | 7.00e-06 | 21 | 209 | 4 | 9449667 | ||
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 22535526 | ||
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 7.36e-06 | 7 | 209 | 3 | 21079652 | |
| Pubmed | EphB regulates L1 phosphorylation during retinocollicular mapping. | 7.36e-06 | 7 | 209 | 3 | 22579729 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 7.36e-06 | 7 | 209 | 3 | 18443296 | |
| Interaction | ACTR1B interactions | 1.73e-05 | 116 | 195 | 8 | int:ACTR1B | |
| Interaction | FAM78B interactions | 1.75e-05 | 6 | 195 | 3 | int:FAM78B | |
| Interaction | KLHL17 interactions | 1.78e-05 | 34 | 195 | 5 | int:KLHL17 | |
| Cytoband | 9q21.11 | 1.02e-05 | 30 | 208 | 4 | 9q21.11 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 5.27e-08 | 14 | 142 | 5 | 1095 | |
| GeneFamily | Fibronectin type III domain containing | EPHB2 EPHB3 EPHB6 EPHA6 OBSCN LRFN4 PTPRZ1 CNTN5 FN1 TNR EPHB1 | 5.43e-08 | 160 | 142 | 11 | 555 |
| GeneFamily | Actins | 9.32e-06 | 6 | 142 | 3 | 929 | |
| GeneFamily | Kelch like|BTB domain containing | 1.87e-05 | 42 | 142 | 5 | 617 | |
| GeneFamily | ATAC complex | 1.28e-04 | 13 | 142 | 3 | 1058 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 1.83e-04 | 3 | 142 | 2 | 912 | |
| GeneFamily | AT-rich interaction domain containing | 2.01e-04 | 15 | 142 | 3 | 418 | |
| GeneFamily | Dyneins, axonemal | 2.98e-04 | 17 | 142 | 3 | 536 | |
| GeneFamily | Sterile alpha motif domain containing | 6.47e-04 | 88 | 142 | 5 | 760 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 6.65e-04 | 134 | 142 | 6 | 861 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 8.51e-04 | 24 | 142 | 3 | 485 | |
| GeneFamily | GCN5 related N-acetyltransferases | 8.51e-04 | 24 | 142 | 3 | 1134 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.08e-03 | 26 | 142 | 3 | 253 | |
| GeneFamily | Transmembrane channel likes | 1.66e-03 | 8 | 142 | 2 | 1135 | |
| GeneFamily | Glucosaminyl (N-acetyl) transferases/xylosyltransferases | 1.66e-03 | 8 | 142 | 2 | 441 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.13e-03 | 9 | 142 | 2 | 1234 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.64e-03 | 10 | 142 | 2 | 53 | |
| GeneFamily | Complement system|Sushi domain containing | 2.80e-03 | 36 | 142 | 3 | 492 | |
| GeneFamily | Immunoglobulin like domain containing | 4.22e-03 | 193 | 142 | 6 | 594 | |
| GeneFamily | PHD finger proteins | 5.53e-03 | 90 | 142 | 4 | 88 | |
| GeneFamily | Beta-gamma crystallins | 6.01e-03 | 15 | 142 | 2 | 1359 | |
| GeneFamily | Chaperonins | 6.01e-03 | 15 | 142 | 2 | 587 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 6.01e-03 | 15 | 142 | 2 | 1296 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 7.71e-03 | 17 | 142 | 2 | 1059 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.71e-03 | 17 | 142 | 2 | 486 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.34e-03 | 53 | 142 | 3 | 532 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.88e-03 | 161 | 142 | 5 | 593 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.27e-02 | 394 | 142 | 8 | 471 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 1.28e-02 | 22 | 142 | 2 | 464 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.44e-08 | 171 | 197 | 9 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-08 | 177 | 197 | 9 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-08 | 177 | 197 | 9 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-07 | 186 | 197 | 9 | b5e094850ac3785775393cd78a939b02339732b0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-07 | 187 | 197 | 9 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-07 | 187 | 197 | 9 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-07 | 199 | 197 | 9 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADAM19 STK17B IL18RAP IL18R1 FAM78A ARHGAP25 CARD11 LY9 FCMR | 2.82e-07 | 200 | 197 | 9 | d8459e45a8396a9ee063666a1928c649162c5727 |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-07 | 150 | 197 | 8 | 57f21ad380fd1350a2c25d75ad8c3b763ded53ec | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.50e-07 | 162 | 197 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.36e-07 | 170 | 197 | 8 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.78e-07 | 171 | 197 | 8 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 177 | 197 | 8 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-06 | 177 | 197 | 8 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 1.44e-06 | 180 | 197 | 8 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-06 | 184 | 197 | 8 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 184 | 197 | 8 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-06 | 184 | 197 | 8 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-06 | 186 | 197 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-06 | 186 | 197 | 8 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.99e-06 | 188 | 197 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.99e-06 | 188 | 197 | 8 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 2.15e-06 | 190 | 197 | 8 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-06 | 191 | 197 | 8 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.24e-06 | 191 | 197 | 8 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 2.33e-06 | 192 | 197 | 8 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 2.33e-06 | 192 | 197 | 8 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.51e-06 | 194 | 197 | 8 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.51e-06 | 194 | 197 | 8 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 2.71e-06 | 196 | 197 | 8 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-06 | 196 | 197 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Biopsy_Other_PF-Immune-B_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.71e-06 | 196 | 197 | 8 | 123cd893fd1ae315a655e909c08528f82e9013ff | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 197 | 197 | 8 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 197 | 197 | 8 | ccabb976b5d4800e87e550640454a893fdb3b1b6 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-06 | 197 | 197 | 8 | 5b172bc2f3f6bd4741600e1ea299c469685eba4f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 197 | 197 | 8 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Biopsy_IPF-Immune-B_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 2.93e-06 | 198 | 197 | 8 | 6a519337a4932a7b685fe7defd3de24fa2016b7d | |
| ToppCell | Biopsy_IPF-Immune-pDCs|Biopsy_IPF / Sample group, Lineage and Cell type | 2.93e-06 | 198 | 197 | 8 | aa8943e6796f619406056cf763b751fe9a9a3e0c | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-06 | 198 | 197 | 8 | 4aa4ae2571effcfb6eb6923f7173cd3e7e4af9ef | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-06 | 198 | 197 | 8 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-06 | 199 | 197 | 8 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-06 | 199 | 197 | 8 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 200 | 197 | 8 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 200 | 197 | 8 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 200 | 197 | 8 | dfdfad881c114e1bc9a64b411e1b00fb37cc859b | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 200 | 197 | 8 | f7a9d8b99de19e9842422bada348d940e0863645 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-06 | 151 | 197 | 7 | 535872e231ac0ee7b4fc4d02a260752cbbf50a2b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-06 | 160 | 197 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-06 | 160 | 197 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.35e-06 | 160 | 197 | 7 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-06 | 161 | 197 | 7 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.30e-06 | 163 | 197 | 7 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 169 | 197 | 7 | 2098f15a388d019ed7f1d4c209affd5ca2886dcc | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 169 | 197 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 170 | 197 | 7 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 170 | 197 | 7 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 171 | 197 | 7 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.18e-05 | 172 | 197 | 7 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.27e-05 | 174 | 197 | 7 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 174 | 197 | 7 | 5bde24eb588dc588efc413811379548120ec0c7f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 174 | 197 | 7 | 1b2a2129c08bac01fc638692313b196759a1e0d7 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 175 | 197 | 7 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.32e-05 | 175 | 197 | 7 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-05 | 177 | 197 | 7 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.42e-05 | 177 | 197 | 7 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 177 | 197 | 7 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | Control-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.42e-05 | 177 | 197 | 7 | e82115bfc32c7b689460fbc5caeb983c1aabe30f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 177 | 197 | 7 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 178 | 197 | 7 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 178 | 197 | 7 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 178 | 197 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 1.47e-05 | 178 | 197 | 7 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | 1.52e-05 | 179 | 197 | 7 | 5b89193486100b6754c1c5eca3105ea955805eae | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.52e-05 | 179 | 197 | 7 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 180 | 197 | 7 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | Control-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.64e-05 | 181 | 197 | 7 | 9124f1a610cfc3355ad87921cd3eb5346956475d | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-05 | 181 | 197 | 7 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 182 | 197 | 7 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 182 | 197 | 7 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 182 | 197 | 7 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 182 | 197 | 7 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.70e-05 | 182 | 197 | 7 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 182 | 197 | 7 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 1.76e-05 | 183 | 197 | 7 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 183 | 197 | 7 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 183 | 197 | 7 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 1.76e-05 | 183 | 197 | 7 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 123 | 197 | 6 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.82e-05 | 184 | 197 | 7 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 184 | 197 | 7 | 6ce9aea2c1c9098f37bdf5135b5e2192ef03b50b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 184 | 197 | 7 | 895f7492d47c4782809bbb125c258127de04f888 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-05 | 184 | 197 | 7 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-05 | 184 | 197 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 185 | 197 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 185 | 197 | 7 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 185 | 197 | 7 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 1.89e-05 | 185 | 197 | 7 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 185 | 197 | 7 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 186 | 197 | 7 | aa88d9573a237b2b8e6025fee31f69fbce824497 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 186 | 197 | 7 | 0096a61b1841784c913752b4f3639200446cc02c | |
| Computational | Genes in the cancer module 80. | 3.99e-05 | 32 | 132 | 5 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 7.19e-05 | 36 | 132 | 5 | MODULE_51 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | ACTA1 ACTA2 ACTC1 ADCY1 ADCY5 PHKG2 PIK3C2G CACNA1B CACNA1C HCN1 CACNG7 CARD11 TOP2B | 2.75e-06 | 308 | 195 | 13 | CID000001915 |
| Drug | C3H2N2O3S | 3.36e-06 | 74 | 195 | 7 | CID000448652 | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A | ADAM19 PDGFRA ADGRB2 ADGRB3 IFIH1 CNTN5 PLCD1 USP53 LSS EPHB1 | 7.42e-06 | 195 | 195 | 10 | 4063_UP |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | 7.76e-06 | 196 | 195 | 10 | 6653_DN | |
| Drug | Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | EPHB2 ZNF671 MTUS1 CD2BP2 PLCD1 FN1 TRMT2A SMARCA2 CCT6B DIXDC1 | 8.48e-06 | 198 | 195 | 10 | 5731_DN |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 9.97e-07 | 4 | 187 | 3 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.37e-05 | 8 | 187 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.37e-05 | 8 | 187 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.37e-05 | 8 | 187 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.37e-05 | 8 | 187 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 2.91e-05 | 10 | 187 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 2.91e-05 | 10 | 187 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | Hypertrophic Cardiomyopathy | 3.11e-05 | 57 | 187 | 5 | C0007194 | |
| Disease | spinocerebellar ataxia type 2 (implicated_via_orthology) | 4.00e-05 | 2 | 187 | 2 | DOID:0050955 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 6.84e-05 | 13 | 187 | 3 | C0265338 | |
| Disease | kynurenine measurement | 1.08e-04 | 39 | 187 | 4 | EFO_0008529 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.32e-04 | 16 | 187 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.32e-04 | 16 | 187 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | neutrophil percentage of leukocytes | ADAM19 ATAD5 IL18R1 ADCY5 ATXN2 ARHGAP25 SERTAD1 EXOC6 MINK1 IRF8 SEC31A LIPA SLC7A5 | 1.50e-04 | 610 | 187 | 13 | EFO_0007990 |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.59e-04 | 43 | 187 | 4 | DOID:9074 (implicated_via_orthology) | |
| Disease | Antibody Deficiency Syndrome | 1.60e-04 | 17 | 187 | 3 | C0003257 | |
| Disease | dodecanoylcarnitine measurement | 2.38e-04 | 4 | 187 | 2 | EFO_0021804 | |
| Disease | X-12100 measurement | 2.38e-04 | 4 | 187 | 2 | EFO_0800701 | |
| Disease | birth weight | ATAD5 PTGR2 ADCY5 KLHL29 ATXN2 EXOC6 ARFGEF2 CLDN7 DCUN1D2 PLEKHA1 | 2.48e-04 | 399 | 187 | 10 | EFO_0004344 |
| Disease | intrinsic cardiomyopathy (implicated_via_orthology) | 3.06e-04 | 21 | 187 | 3 | DOID:0060036 (implicated_via_orthology) | |
| Disease | lymphocyte percentage of leukocytes | ACTA2 IL18RAP ADCY5 ATXN2 CNTN5 ARHGAP25 SERTAD1 EXOC6 MINK1 IRF8 LIPA CARD11 LY9 | 3.45e-04 | 665 | 187 | 13 | EFO_0007993 |
| Disease | Small cell carcinoma of lung | 3.86e-04 | 54 | 187 | 4 | C0149925 | |
| Disease | decenoylcarnitine measurement | 3.95e-04 | 5 | 187 | 2 | EFO_0021803 | |
| Disease | interleukin-18 receptor 1 measurement | 3.95e-04 | 5 | 187 | 2 | EFO_0801721 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.95e-04 | 5 | 187 | 2 | C3281201 | |
| Disease | Immunologic Deficiency Syndromes | 4.04e-04 | 23 | 187 | 3 | C0021051 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.14e-04 | 55 | 187 | 4 | C0079744 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.31e-04 | 152 | 187 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 4.95e-04 | 156 | 187 | 6 | DOID:10283 (is_marker_for) | |
| Disease | Left Ventricular Hypertrophy | 5.20e-04 | 25 | 187 | 3 | C0149721 | |
| Disease | interleukin-1 receptor-like 1 measurement | 5.89e-04 | 6 | 187 | 2 | EFO_0801713 | |
| Disease | nonanoylcarnitine (C9) measurement | 5.89e-04 | 6 | 187 | 2 | EFO_0800381 | |
| Disease | hypertension (biomarker_via_orthology) | 6.39e-04 | 227 | 187 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Sezary Syndrome | 6.55e-04 | 27 | 187 | 3 | C0036920 | |
| Disease | pneumonia, COVID-19 | 7.82e-04 | 113 | 187 | 5 | EFO_0003106, MONDO_0100096 | |
| Disease | laurylcarnitine measurement | 8.22e-04 | 7 | 187 | 2 | EFO_0021041 | |
| Disease | aortic dissection (is_marker_for) | 1.09e-03 | 8 | 187 | 2 | DOID:0080685 (is_marker_for) | |
| Disease | cis-4-decenoylcarnitine (C10:1) measurement | 1.09e-03 | 8 | 187 | 2 | EFO_0800311 | |
| Disease | Ischemic stroke | 1.13e-03 | 324 | 187 | 8 | HP_0002140 | |
| Disease | Complement deficiency disease | 1.19e-03 | 33 | 187 | 3 | C0272242 | |
| Disease | neutrophil-to-lymphocyte ratio | 1.20e-03 | 185 | 187 | 6 | EFO_0008447 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.27e-03 | 74 | 187 | 4 | DOID:3748 (is_marker_for) | |
| Disease | celiac disease | 1.27e-03 | 126 | 187 | 5 | EFO_0001060 | |
| Disease | acylcarnitine measurement | 1.32e-03 | 127 | 187 | 5 | EFO_0005059 | |
| Disease | octanoylcarnitine measurement | 1.40e-03 | 9 | 187 | 2 | EFO_0021042 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.40e-03 | 9 | 187 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 1.41e-03 | 35 | 187 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | Burkitt Lymphoma | 1.53e-03 | 36 | 187 | 3 | C0006413 | |
| Disease | Mitral valve prolapse | 1.53e-03 | 36 | 187 | 3 | HP_0001634 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.57e-03 | 195 | 187 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | coronary artery disease | ADAM19 STK32B DOK3 KAT2A IFIH1 ATXN2 PCDH18 EXOC6 FN1 UBD HCN1 ARFGEF2 CCT6A LIPA SMARCA4 CORO6 PCCB | 1.62e-03 | 1194 | 187 | 17 | EFO_0001645 |
| Disease | complement C1q subcomponent subunit C measurement | 1.74e-03 | 10 | 187 | 2 | EFO_0801492 | |
| Disease | hormone measurement | 2.03e-03 | 84 | 187 | 4 | EFO_0004730 | |
| Disease | neuroticism measurement | KLHL2 ACTA1 PBDC1 ETFDH SRP9 KLHL29 CNTN5 UNC5D UBD HCN1 ELAVL2 CARD11 PCCB EPHB1 | 2.06e-03 | 909 | 187 | 14 | EFO_0007660 |
| Disease | interleukin 1 receptor-like 1 measurement | 2.12e-03 | 11 | 187 | 2 | EFO_0008168 | |
| Disease | serum ST2 measurement | 2.12e-03 | 11 | 187 | 2 | EFO_0005416 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 2.12e-03 | 11 | 187 | 2 | C1335302 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.53e-03 | 12 | 187 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | decanoylcarnitine measurement | 2.53e-03 | 12 | 187 | 2 | EFO_0021039 | |
| Disease | Depressive disorder | 2.55e-03 | 289 | 187 | 7 | C0011581 | |
| Disease | suicide behaviour measurement | 2.57e-03 | 43 | 187 | 3 | EFO_0006882 | |
| Disease | spleen volume | 2.57e-03 | 43 | 187 | 3 | EFO_0600047 | |
| Disease | left ventricular systolic function measurement | 2.74e-03 | 44 | 187 | 3 | EFO_0008206 | |
| Disease | Anxiety States, Neurotic | 2.74e-03 | 44 | 187 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 2.74e-03 | 44 | 187 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 2.74e-03 | 44 | 187 | 3 | C0003469 | |
| Disease | body weight | ATXN2L EPHA6 ATAD5 VPS13C ADGRB3 LRP1B ADCY5 DNAH14 CACNA1B CACNA1C PRMT6 FEZ2 CADPS ELAVL2 PLEKHA1 PATJ EPHB1 | 2.86e-03 | 1261 | 187 | 17 | EFO_0004338 |
| Disease | executive function measurement | 2.86e-03 | 376 | 187 | 8 | EFO_0009332 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.92e-03 | 45 | 187 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 2.92e-03 | 45 | 187 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | S-warfarin measurement | 3.42e-03 | 97 | 187 | 4 | EFO_0803323 | |
| Disease | neuroticism measurement, cognitive function measurement | ATXN2L KLHL2 LRP1B KLHL29 CACNA1C HCN1 ELAVL2 PLEKHA1 TNR EPHB1 | 3.43e-03 | 566 | 187 | 10 | EFO_0007660, EFO_0008354 |
| Disease | malignant pleural mesothelioma (is_marker_for) | 3.46e-03 | 14 | 187 | 2 | DOID:7474 (is_marker_for) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.60e-03 | 160 | 187 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Hepatic fibrosis | 3.73e-03 | 49 | 187 | 3 | HP_0001395 | |
| Disease | interleukin 18 receptor 1 measurement | 3.97e-03 | 15 | 187 | 2 | EFO_0008178 | |
| Disease | African Burkitt's lymphoma | 3.97e-03 | 15 | 187 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 3.97e-03 | 15 | 187 | 2 | C4721444 | |
| Disease | sitting height ratio | 4.17e-03 | 51 | 187 | 3 | EFO_0007118 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 4.24e-03 | 103 | 187 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Schizophrenia | IL18R1 TXNDC5 ATXN2 PTPRZ1 CACNA1B CACNA1C SLC6A3 TRMT2A ERVK-8 SMARCA2 ELAVL2 DIXDC1 NPAS4 | 4.30e-03 | 883 | 187 | 13 | C0036341 |
| Disease | response to acetylsalicylate | 4.52e-03 | 16 | 187 | 2 | GO_1903492 | |
| Disease | urinary bladder cancer (is_marker_for) | 4.85e-03 | 107 | 187 | 4 | DOID:11054 (is_marker_for) | |
| Disease | Glycogen storage disease | 5.10e-03 | 17 | 187 | 2 | cv:C0017919 | |
| Disease | serine measurement, amino acid measurement | 5.10e-03 | 17 | 187 | 2 | EFO_0005134, EFO_0009774 | |
| Disease | mean reticulocyte volume | STK17B SRP9 KAT2A EZH2 KAT2B CD82 ATXN2 CNTN5 ABCC1 AIP CRYBA1 SLC7A5 | 5.15e-03 | 799 | 187 | 12 | EFO_0010701 |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 5.43e-03 | 56 | 187 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Mental Depression | 5.77e-03 | 254 | 187 | 6 | C0011570 | |
| Disease | large artery stroke | 5.88e-03 | 113 | 187 | 4 | EFO_0005524 | |
| Disease | colon cancer (is_marker_for) | 6.28e-03 | 59 | 187 | 3 | DOID:219 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PMVAAEVGVWDNYCV | 486 | P40227 | |
| IDQDYASAFEPMNEW | 946 | Q13075 | |
| GLYMAQTGDPAAEEW | 301 | O60241 | |
| DSGTEDMLWTEKYQP | 1046 | Q96QE3 | |
| DMLWTEKYQPQTASE | 1051 | Q96QE3 | |
| QWYDLTEDGTRPQAM | 906 | A0FGR8 | |
| ANTAWMENPEEAIYD | 226 | O15013 | |
| QMEQPGEYISSVAWI | 221 | Q12834 | |
| TWMDNPIEVYVNDSV | 6 | O42043 | |
| VTWMDNPIEVYVNDS | 116 | O71037 | |
| VTWMDNPIEVYVNDS | 116 | Q902F8 | |
| VTWMDNPIEVYVNDS | 116 | Q9UKH3 | |
| NPMGTNEYLSAIWAV | 331 | Q96FN4 | |
| SQEFMGQLYQWEPFT | 396 | Q6UY14 | |
| YLLDSNSWIEEMPSE | 1701 | P0C0L5 | |
| EWLANPSNDMYADTV | 566 | Q9UKF6 | |
| YPIEHGIITNWDDME | 71 | P68133 | |
| QMWITKQEYDEAGPS | 356 | P68133 | |
| WEDAQQIYPGSIELM | 661 | O60242 | |
| GNMCEVSENPYSTLW | 266 | Q9H013 | |
| IGLQWENMYTSPVQD | 1231 | Q86UK0 | |
| SMDEEIENPYWSVRA | 186 | Q155Q3 | |
| NTYSDLGMSSWELPD | 81 | Q5VT40 | |
| VSMNDNFYPSVTWAV | 136 | Q5VT40 | |
| GDYAMWSITPDTSIQ | 2361 | Q7Z2Y8 | |
| YPIEHGIITNWDDME | 71 | P62736 | |
| QMWISKQEYDEAGPS | 356 | P62736 | |
| YTSDDMNVAPGDRVW | 1311 | Q9Y6D5 | |
| DYGSFSEIMQPWAQT | 1956 | Q13085 | |
| YDIWGNTVNVASRMD | 1196 | O95622 | |
| PVGMSSDSYIWDLEN | 191 | Q9GZS0 | |
| ENDNGSWTPYDMEVG | 96 | Q9Y2E6 | |
| ITMEGWTDILYNTND | 311 | Q00975 | |
| DMSNYDEEGAWPVLI | 226 | Q96GG9 | |
| EMAENYFQLSVDWPE | 361 | O95905 | |
| YDLESDMSNGWDPNE | 241 | Q8WWM7 | |
| GTYQQDPWAMTDEEK | 161 | O00170 | |
| YNWTDNAELMNRPEV | 156 | P27701 | |
| ESAMAVDLNPWVEYE | 731 | O94779 | |
| SESEAEGESWYPTNM | 891 | Q5T481 | |
| EGESWYPTNMEELVT | 896 | Q5T481 | |
| SDNDAYWVMNAPTVA | 276 | O94810 | |
| SMLEEEIYGANSPIW | 361 | Q92830 | |
| GWEYMKPDSEENRSN | 631 | O75747 | |
| NVSMDSVPYTEWELS | 641 | Q9HCL0 | |
| GVYIGSVMPNDSEWE | 941 | O94822 | |
| GWSPVYVEDNLGVMS | 116 | P53384 | |
| ALDYNNDTPLSWAAM | 146 | Q9H765 | |
| GESEVSWQYPMSEEE | 51 | P16234 | |
| SAPSWMAAIYDADNG | 1046 | Q9ULU8 | |
| EETDYTPVWCMRQAG | 26 | P06132 | |
| GPVDAQVYLEEMSWN | 91 | Q6P3W2 | |
| GERPYWDMSNQDVIN | 821 | P54762 | |
| VIYWMFGEENGSDPN | 246 | Q13478 | |
| LPFMGSNDLSDVQWY | 71 | O95256 | |
| SMGIAWPNGISIDYE | 2036 | Q9NZR2 | |
| SMLEEEVYSQNSPIW | 351 | Q92831 | |
| SEYAADPWVQDQMQR | 106 | Q8WVJ2 | |
| EWGYMPTLRNGLEEN | 111 | Q2TV78 | |
| WNSANPDDMVVDYET | 46 | Q9ULD2 | |
| QVWLEPEGMDSDLIY | 331 | Q9Y2Z2 | |
| YWSLDPASQDMFDNG | 181 | Q8WXT5 | |
| YWSLDPASQDMFDNG | 181 | Q6VB84 | |
| MNISQIISYWGYPDE | 1 | Q5W064 | |
| DVSNGWDPNDMFRYN | 391 | Q99700 | |
| DMSNYDEEGAWPVLI | 226 | Q6PH85 | |
| PYWDMTNQDVINAIE | 826 | P29323 | |
| MDDPTVNWSIERYEE | 351 | Q8IYD1 | |
| YSWSPLQQNFMVEDE | 111 | Q15910 | |
| SWQEDLENMYLDTPR | 231 | Q9GZP0 | |
| QWYMNSEAQPDLSIL | 126 | Q6UW60 | |
| EQIDSSMYPGLIWEN | 16 | Q02556 | |
| MGDWNNSDAVEPIFI | 1 | Q8NGJ5 | |
| AESYGNDPDIEMAWA | 26 | Q9BVG4 | |
| DSYPDVLAMQFNWDG | 326 | P21128 | |
| SDEGDVSWMEEQLSY | 61 | Q9H8E8 | |
| ELNPDQSNLMYWAVD | 1161 | O94915 | |
| NVYSWEGLNTLFPEM | 201 | P48449 | |
| GWNYLNFVTEEMINP | 256 | Q01650 | |
| PMEENSIYSSWQEVG | 201 | Q7L591 | |
| GWEEVSGYDEAMNPI | 61 | P54753 | |
| ERPYWDMSNQDVINA | 836 | P54753 | |
| LSWDYMQSDLGELPV | 31 | P00451 | |
| WTLDPDSYNMFENGS | 146 | Q99958 | |
| EEEYLDSGWNLNNMP | 451 | Q9UGL1 | |
| RNQAWMSYAGENELP | 1736 | Q6ZVL6 | |
| MSYAGENELPSQWAD | 1741 | Q6ZVL6 | |
| WMGLVDPEDGETIYA | 66 | A0A0G2JMI3 | |
| IPDGQNMAEDEFVYW | 2121 | P23471 | |
| MEFPWVVSLQDSQYT | 51 | Q6PEW0 | |
| VTWMDNPIEIYVNDS | 876 | P63135 | |
| EPMEYSVVVWSSGVD | 216 | Q8TCD6 | |
| MEGQYQFSSPEWDDR | 246 | P15735 | |
| EFVQLADYDWTMSEP | 611 | Q8TAG9 | |
| EEYALSGWNLNNMPV | 436 | P29375 | |
| RTDSSNYSPVEMWNG | 556 | P51178 | |
| EEVEWSLNGMPLYND | 2586 | Q5VST9 | |
| TNYAWPTAEIAVMGA | 451 | P05166 | |
| NYPISDMEAWSLRQQ | 311 | Q8IUM7 | |
| SSDGTYMWDEEGLEP | 506 | Q9H7U1 | |
| YGPFTSAQMQTWVSE | 296 | O95400 | |
| SAQMQTWVSEGYFPD | 301 | O95400 | |
| SWPEFYIDQLNSMAA | 101 | Q9Y4D1 | |
| SWMGEQAEALGVEVY | 181 | Q16134 | |
| YDIWGNTVNVASRMD | 996 | Q08828 | |
| YGAQAPVSMSDLWIT | 361 | O60741 | |
| YNPETDTWTRVGSMN | 356 | O94889 | |
| IYNSESDEWTEGLPM | 341 | Q8NBE8 | |
| YDPISDTWLDSAGMI | 546 | Q9NXS3 | |
| QILTGEDWNSVMYDG | 701 | Q13936 | |
| TWMDNPIEVYVNDSE | 6 | P61566 | |
| VTWMDNPIEVYVNDS | 116 | P61570 | |
| VTWMDNPTEVYVNDS | 116 | Q69384 | |
| TWMDNPIEIYVNDSV | 6 | P61567 | |
| TTNEGVMYRIGDQWD | 471 | P02751 | |
| LPYDQSTWEEDEMNI | 656 | Q12873 | |
| AYNGENWRTSITDME | 216 | O75718 | |
| ISDDYPSLQAMGWFN | 141 | P05813 | |
| FDGPVDAVWIENMNT | 1691 | Q8WXX0 | |
| SDFGTQPYEQWAIQM | 571 | Q9BYX4 | |
| GWMVTSLPLYNDDDL | 596 | Q7Z388 | |
| PEQVDAIVSEWMGYG | 146 | Q96LA8 | |
| DYWLYMEEGTVLPQN | 31 | P62955 | |
| ELSDDYPSLQAMGWE | 121 | P53673 | |
| SDDTTIMVWQIPDYT | 101 | Q6QEF8 | |
| LYGQLDPNTMEWTDG | 1486 | Q0VDD8 | |
| TWMDNPIEVYVNDSV | 116 | P61565 | |
| TWMDNPIEVYVNDSV | 6 | Q9HDB8 | |
| YNLAPDADESILWQM | 281 | Q12926 | |
| FPLDVQWNDLDYMDS | 396 | P10253 | |
| EDGGNTVMYTWTPLQ | 386 | Q9HBG7 | |
| DDMNWYQQKPGEAAI | 51 | P06315 | |
| VTWMDNPIEIYVNDS | 116 | Q902F9 | |
| SENFTSPYVWMLDAE | 471 | Q9UKA1 | |
| DVVYSQVWSMQQPES | 471 | Q96LA5 | |
| QKLMEWAQDTYSPDE | 306 | Q02742 | |
| IWGANAYVTDEDSMI | 161 | Q86WA6 | |
| QFEGMQLPAASELEW | 636 | Q92622 | |
| GSYNTNEDMEPDWLT | 596 | O00237 | |
| ATYKTMGPAWDQQEE | 46 | Q15020 | |
| IYEAPDVMNLSQWSL | 141 | Q96EE3 | |
| GMDMWSTQDLYDNPV | 26 | P56856 | |
| LYATVEPDMWGSVEE | 1116 | Q9BXL7 | |
| GLWTVQAMDPNAAYV | 16 | P08185 | |
| ADLMQEWGDAVQYNP | 446 | P07358 | |
| YLLDSNSWIEEMPSE | 1701 | P0C0L4 | |
| WIPSQEMGYNCFSLE | 146 | A0A1W2PPM1 | |
| WNALTDNYGNVMPVD | 91 | Q9UHY8 | |
| MWVDSGSIVIPYDNI | 151 | Q12908 | |
| TYPLNGWDAITEMDE | 51 | Q9UF33 | |
| PYWEMSNQDVILSIE | 876 | Q9UF33 | |
| DVVLQWGEMPTSVAY | 1246 | Q8N4C8 | |
| MNLDPFSQYSDEEVW | 1386 | P33527 | |
| GNQPDQEMVSASEWY | 186 | P32754 | |
| STYWEGNPEMETLQR | 361 | A2RTX5 | |
| LTNQSDWDSPYLDME | 346 | Q9H987 | |
| WAQAPLSDTAQVYME | 971 | Q5ST30 | |
| EWTASPYQAAEQDMR | 236 | Q8NBJ7 | |
| YTVIQDWAQLDAGSM | 421 | Q8IZ69 | |
| WDMYGPQTQLEEDAI | 391 | Q8IYL2 | |
| PMVAADAGVWDNYCV | 486 | Q92526 | |
| QLDAWLEMNPGYEVA | 616 | P51531 | |
| LYDSDWNPQVDLQAM | 591 | P28370 | |
| EPLTQFMWVYDEDVG | 76 | Q02880 | |
| NQYGEQGMSSWELPD | 101 | Q5JUQ0 | |
| ISMNDNFYPSVTWAV | 156 | Q5JUQ0 | |
| YWSLDPASQDMFDNG | 181 | Q5VV16 | |
| YWSLDPASQDMFDNG | 181 | Q3SYB3 | |
| PYWDMSEQEVLNAIE | 861 | O15197 | |
| QQMWISKQEYDESGP | 1016 | P0CG39 | |
| AGQLEAWLEMNPGYE | 636 | P51532 | |
| ILNYDPITTATDMWN | 206 | O94768 | |
| LQETGFIEYMDQGPW | 491 | Q9UKZ4 | |
| DIDTSMYDNELWAPA | 176 | Q9UHV2 | |
| YPIEHGIITNWDDME | 71 | P68032 | |
| QMWISKQEYDEAGPS | 356 | P68032 | |
| AIPQWQMSSYAGDNI | 26 | O95471 | |
| MHEEEIYTSLQWDSP | 1 | Q6UXN8 | |
| GDNWQMQRTESGYES | 676 | Q70EK8 | |
| EPDDYSTQWNLVMEK | 136 | Q9UKR8 | |
| EWDLMTFDANPYDSV | 16 | O15205 | |
| VQWDEDSVEYMPANP | 311 | Q86Y38 | |
| EPWVYDQVDMTSATE | 106 | Q8TAW3 | |
| MLENYGNVTSLEWET | 246 | O14709 | |
| EDYGPNGLDIEWMQV | 51 | P0DPA2 | |
| ADTEMWPVYVELTNE | 291 | Q8WU10 | |
| WENLLGPDYEVMVAT | 531 | Q8NI35 | |
| PASWDQNRMGQDSYV | 116 | P42331 | |
| PTDRYMWSDASGLQE | 841 | Q7Z6L1 | |
| VYWATGCTVELQEMP | 366 | Q7Z404 | |
| DDIQQMTGQRPSLYW | 506 | Q01959 | |
| NVHSEYEPSWEEQPM | 121 | O60667 | |
| QIWGYMESQNLADFP | 16 | Q2M296 | |
| VTWMDNPIEVYVNDS | 876 | P10266 | |
| SIELEWDGPMAVTEY | 341 | Q92752 | |
| VTWMDNPIEVYVNDS | 876 | Q9UQG0 | |
| EIASDGSMPTNKWNY | 2886 | Q709C8 | |
| IPEENSWEIYMSINQ | 571 | Q6UXZ4 | |
| SWEIYMSINQGEPSL | 576 | Q6UXZ4 | |
| EDAVYWEMPEGNSTV | 431 | Q9UBD6 | |
| VDNMPVTWCYDVEDG | 156 | Q99805 | |
| QPTWNDLGDKYNSME | 96 | Q8NBS9 | |
| DDVMDYLVNNTPLNW | 386 | Q99541 | |
| DIQSVPYLADMNWDA | 276 | Q9NY57 | |
| MPQYQTWEEFSRAAE | 1 | P49458 | |
| LWGENDYPEGIEMAS | 286 | Q6UXY8 | |
| QWIVDMEGAPGTLYE | 36 | Q96B02 | |
| YQMNDSSWVQDGSPE | 531 | Q96DT7 | |
| MYFSQEEWELLDPTQ | 1 | Q96N20 | |
| LYDSDWNPQVDLQAM | 576 | O60264 | |
| EDSFVWYMDNPQNLP | 36 | Q9HB21 | |
| EIYIWDLNNFATPMT | 146 | O94979 | |
| YQREDMSLAQSPGIW | 206 | Q2TAA8 | |
| AAPIEMEEASVYSQW | 1126 | Q6ZQQ6 | |
| MNEDTGTDYITPWQL | 56 | Q8N8N7 | |
| EEEDCTWMQEYNPPT | 31 | Q9Y2L8 | |
| MGYESSAERWSPVQS | 101 | P60604 | |
| AYNCVAIDTDMSPWE | 846 | Q5T447 | |
| ALGNMEAYEPTTNTW | 836 | Q96CT2 | |
| YDPTTNAWRQVADMN | 516 | O95198 | |
| EEEYATSGWNLNVMP | 466 | P41229 | |
| PETNMNVSEIISYWG | 31 | P38571 | |
| PVWMFQIQYNSSEDE | 431 | Q6PJG9 |